Table 2. Incidence, mortality, cost, effectiveness, ICER, and undiscounted ICER of 11 strategies compared with no screening strategy.

Strategies	Incidence(No of cases)	Mortality(No of cases)	Cost($)	QALY	ICER(US $/QALY)	Undiscounted ICER
No screening	1321	509	13.93	24.406	0	0
HPV 35–10	940	363	42.89	24.409	8,875	2,472
Pap smear35-10	591	229	45.39	24.409	9,080	2,589
HPV 35–5	727	281	63.69	24.411	9,087	2,554
Pap smear 35–5	779	300	66.24	24.411	9,650	2,747
HPV 30–5	674	259	76.94	24.412	10,248	2,978
HPV 30 10	933	359	50.20	24.409	10,695	3,069
Pap smear 30–5	731	281	81.03	24.412	11,189	3,276
Pap smear 30–10	974	375	53.75	24.409	11,193	3,261
Pap smear 35–3	611	236	94.70	24.413	11,362	3,251
Pap smear 30–3	543	208	119.30	24.413	13,342	3,920
Pap smear 21–3	483	184	192.04	24.414	20,492	6,234